Isatuximab in Multiple Myeloma

(August 27, 2019)

The addition of isatuximab to pomalidomide and low-dose dexamethasone significantly improved PFS and overall response rate among patients with relapsed or refractory multiple myeloma, according to randomized phase 3 study results presented at ASCO Annual... Continue Reading


FDA Approves New Treatment for Multiple Myeloma

(July 5, 2019)

The FDA has granted accelerated approval to selinexor (Xpovio; Karyopharm Therapeutics) tablets in combination with the corticosteroid dexamethasone for the treatment of adults with relapsed or refractory multiple myeloma who received ≥4 previous therapies... Continue Reading


Darzalex Approved for Newly Diagnosed Stem Cell Transplant Ineligible Multiple Myeloma Patients

(July 1, 2019)

Darzalex (daratumumab) in combination with Revlimid (lenalidomide) and dexamethasone has been approved by the US Food and Drug Administration for treatment of patients with newly diagnosed multiple myeloma who are ineligible for autologous stem cell transplant. Approval... Continue Reading


U.S. Food and Drug Administration Approves Empliciti® Plus Pomalidomide to Treat Certain Patients with Relapsed or Refractory Multiple Myeloma

(November 12, 2018)

The U.S. Food and Drug Administration (FDA) has approved Empliciti (elotuzumab) injection for intravenous use in combination with pomalidomide and dexamethasone (EPd) for the treatment of adult patients with multiple myeloma who have received at least... Continue Reading


AbbVie and the International Myeloma Foundation Partner to Study Role of a Genetic Mutation in Multiple Myeloma

(March 28, 2018)

AbbVie a research and development-based global biopharmaceutical company, and the International Myeloma Foundation (IMF) today announced they have entered into a collaboration to conduct a landmark retrospective chart review study to better understand... Continue Reading


CRISPR Enhances Cancer Immunotherapy

(March 14, 2018)

Gene editing expands reach of therapeutic T cells, in mice CancerConnect News: Last year, the Food and Drug Administration approved the first cellular immunotherapies to treat cancer. These therapies involve collecting a patient’s own immune cells —... Continue Reading


Darzalex-Effective Treatment for Smoldering Multiple Myeloma

(March 7, 2018)

CancerConnect News: The use of Darzalex (daratumumab) in smoldering myeloma may be effective in delaying the time to disease progression. These results were presented at the 2017 annual meeting of the American Society of Hematology (ASH). Multiple myeloma... Continue Reading


Kyprolis Improves Survival in Recurrent Multiple Myeloma

(February 8, 2018)

CancerConnect News: The addition of Kyprolis® (carfilzomib) to the standard treatment regimen, Revlimid® (lenalidomide) and dexamethasone, improves survival for patients with multiple myeloma whose disease progressed or recurred following prior therapies.... Continue Reading


Diagnosed with Multiple Myeloma: 10 Tips on How to Get The Most From Your Doctor

(February 7, 2018)

1) Choose Your Doctor Carefully Hematologists and oncologists are the primary doctors involved with multiple myeloma and often work in collaboration with stem cell transplant physicians. Pick your primary hematologist/oncologist carefully, rely on people... Continue Reading


Xgeva Approved for The Treatment of Multiple Myeloma

(January 17, 2018)

CancerConnect News: The US Food and Drug Administration (FDA) has expanded the approval of Xgeva (denosumab) for the prevention of skeletal-related events in patients with bone metastasis from multiple myeloma. In multiple myeloma, plasma cells infiltrate... Continue Reading


Latest Multiple Myeloma News By Stage


Recurrent Multiple Myeloma

Sorry, there are no articles available for this cancer stage.

More Recurrent Multiple Myeloma

Stage I/Smoldering Myeloma Multiple Myeloma

Sorry, there are no articles available for this cancer stage.

More Stage I/Smoldering Myeloma Multiple Myeloma

Stages II-III Multiple Myeloma

Sorry, there are no articles available for this cancer stage.

More Stages II-III Multiple Myeloma